China’s Duyiwei Biological Acquires Two Hospitals, One More Soon
This article was originally published in PharmAsia News
Executive Summary
Gansu Duyiwei Biological Pharmaceutical Co. Ltd. plans to acquire Pengxi TCM Hospital, according to the company secretary, which follows two other purchases that include Deyang Better Future Hospital Co. Ltd. at RMB 25 million ($4 million) and Ziyang Jianshunwang Check-up Hospital Co. Ltd. for RMB 40 million.